Humacyte

Humacyte is a publicly traded biotechnology company dedicated to developing and producing bioengineered human tissues that can address significant medical needs. Their initial focus is on vascular repair, reconstruction, and replacement using their Human Acellular Vessel™ (HAV™) technology. The HAV is being studied in clinical trials for multiple applications, including vascular trauma repair, AV access for hemodialysis, and peripheral arterial disease. Humacyte's vision extends beyond vascular applications, with preclinical development underway for coronary artery bypass grafts, pediatric heart surgery, and treatment of type 1 diabetes.

Humacyte's mission is to improve and save the lives of patients worldwide through regenerative medicine. They have developed a scalable platform technology that enables the production of bioengineered human tissues at a commercial scale, with a focus on creating readily available solutions for patients with unmet medical needs. They are committed to creating a positive and inclusive work environment for their employees and believe in the transformative potential of their technology to revolutionize healthcare.

Humacyte offers a hybrid work environment, allowing for a balance between in-office and remote work. This flexibility caters to individual preferences and helps employees maintain a healthy work-life balance. The company also provides 23 days of paid time off, 10 company-designated holidays, and two floating holidays, further enhancing the overall work flexibility and providing ample opportunities for personal time and relaxation.

Humacyte offers a competitive benefits package to its employees, including stock options, a 401k plan with a 4% match and no vesting schedule, comprehensive medical, vision and dental plans, company-paid long-term and short-term disability, company-paid life insurance, 23 days of paid time off, 10 company-designated holidays plus two floating holidays, and paid parental leave policies.

Humacyte's mission is to develop and deliver universally implantable bioengineered human tissues, advanced tissue constructs, and organ systems designed to improve the lives of patients and transform the practice of medicine. The company focuses on developing and manufacturing acellular tissues to treat a wide range of diseases, injuries, and chronic conditions, with an initial focus on vascular applications. Humacyte's vision is to create a future where bioengineered tissues are readily available to address unmet medical needs, improving patient outcomes and revolutionizing healthcare.

Humacyte promotes a culture that prioritizes collaboration, innovation, and a commitment to improving patient lives. They value diversity and inclusion, striving to create a welcoming environment where everyone feels a sense of belonging. Their team of talented employees are passionate about the cutting-edge technology they develop and work together to advance the field of regenerative medicine. The company's environment is fast-paced and dynamic, with a focus on achieving ambitious goals and making a meaningful impact on the world.

Humacyte emphasizes creating a culture of belonging through its commitment to diversity, equity, and inclusion. They actively strive to be part of the positive change they seek to see in the world, recognizing the importance of listening and appreciating differences. Humacyte is dedicated to building an inclusive and sustainable work culture where all team members feel a sense of belonging. This commitment extends to attracting a wider pool of qualified applicants and creating a welcoming environment for everyone at all levels of the organization.